Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Mechanism of action revealed for Theratechnologies' Protectazem

Sep. 29, 1997

Endothelin agonists/antagonists from Texas Biotechnology

Sep. 29, 1997

New Na+/H+-exchange inhibitors from Fujisawa

Sep. 26, 1997

FDA grants final marketing approval for Corlopam

Sep. 25, 1997

Irbesartan introduced in first markets

Sep. 25, 1997

VasoCare reduces stress in animal model of hypertension

Sep. 24, 1997

Novel iron complex available for licensing from MoliChem Medicines

Sep. 24, 1997

Merck KGaA claims new Na+/H+-exchange inhibitors

Sep. 24, 1997

Cardizem Monovial approved for U.S. marketing

Sep. 23, 1997

Andrx's extended-release diltiazem receives tentative approval

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...